Toolkit para la creación de unidades de úlcera de pie diabético / A toolkit to create diabetic foot ulcer units

Bajo el nombre de «Toolkit para unidades de úlcera de pie diabético» se han diseñado un conjunto de herramientas para facilitar la puesta en marcha, el funcionamiento y la evaluación de este tipo de unidades clínicas. El Toolkit ha sido realizado por 6 cirujanos vasculares y 2 metodólogos, y para su elaboración se han consultado las principales guías de práctica clínica en el manejo del pie diabético. El Toolkit incluye material destinado a atención primaria y otras especialidades fuera del ámbito de la cirugía vascular (conceptos básicos, algoritmos de manejo, recomendaciones de prevención primaria y criterios de derivación a cirugía vascular), y material para el propio servicio de cirugía vascular (recomendaciones sobre los recursos necesarios para montar una unidad de úlcera de pie diabético, algoritmos clínicos de manejo, cuadernos de recogida de datos, base de datos en Microsoft Access y herramientas de evaluación clínica y económica de la unidad) (AU)

Under the name of «The Diabetic Foot Ulcer Units Toolkit» we have designed a set of tools as an aid for the implementation, performance and evaluation of these Clinical Units. The Toolkit has been prepared by 6 vascular surgeons and 2 experts in methodology. Major clinical practice guidelines in the management of diabetic foot were consulted. The Toolkit includes tools for primary care and other specialties outside the field of vascular surgery (basic concepts, criteria for referral to DFUU, initial basic tests and recommendations for clinical management and primary prevention), and tools for vascular surgery service (list of optimal resources for the DFUU implementation, clinical management algorithms, data collection forms, Microsoft Access database, and tools for the clinical and economical evaluation) (AU)

Documento de consenso sobre el tratamiento de las infecciones en el pie del diabético / Consensus document on the treatment of diabetic foot infections

La infección del pie diabético, sobre todo si se asocia a isquemia, es la causa más frecuente de amputación de la extremidad inferior en la población general, de ingreso hospitalario y de disminución de la calidad de vida en los diabéticos. El 15% de los diabéticos van a sufrir a lo largo de su vida una infección del pie, con una incidencia anual del 1-4%, precedida en más del 80% de los casos de una úlcera en el pie. Son infecciones complejas en cuyo pronóstico influyen muchos factores, dependientes de la úlcera (localización, extensión, cronicidad, amputación previa, grado de isquemia) y del paciente (edad, insuficiencia renal, tiempo de evolución de la diabetes, comorbilidad asociada), lo que hay que tener en cuenta a la hora de plantear su tratamiento. Las infecciones deben clasificarse en función de su gravedad (leves, moderadas-leves, moderadas-graves y graves). Su tratamiento es complejo y debe ser multidisciplinar; debe incluir desbridamiento, descarga, antibioticoterapia adecuada, revascularización y cura de la úlcera.En este documento de consenso, fruto de la colaboración de la Sociedad Española de Angiología y Cirugía Vascular (SEACV), Sociedad Española de Medicina Interna (SEMI), Sociedad Española de Quimioterapia (SEQ), Asociación Española de Cirujanos (AEC), Sociedad Española de Medicina de Urgencias y Emergencias (INFURG-SEMES) y Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC), se desarrollan las pautas, basadas en la mejor evidencia disponible, de las infecciones de pie diabético, encaminadas a obtener la mayor eficacia clínica(AU)

Diabetic foot infection, particularly if it is associated to ischaemia, is the most common cause of lower limb amputation, in the general population, of hospital admissions, and a decrease in the quality of life in diabetics. Of all diabetics, 15% of them are going to suffer from a foot infection during their life, with an annual incidence of 1-4%, preceded by a foot ulcer in more than 80% of cases. They are complex infections and the prognosis is influenced by many factors, depending on the ulcer (location, extension, whether chronic or not, previous amputation, ischaemia grade), and the patient (age, renal impairment, time of onset of diabetes, associated comorbidity). All these must be taken into account when establishing its treatment. The infections must be classified according to their severity (mild, moderate-mild, moderate-severe, and severe). Their treatment is complex and must be multidisciplinary and must include debridement, discharge, adequate antibiotic therapy, revascularisation, and treatment of the ulcer. In this consensus document, produced in collaboration with the Spanish Angiology and Vascular Surgery Society (SEACV), the Spanish Society of Internal Medicine (SEMI), the Spanish Chemotherapy Society (SEQ), the Spanish Surgeons Association (AEC), the Spanish Society of Urgent Medicine and Emergencies (INFURG-SEMES) and the Spanish Society of Intensive and Critical Medicine and Coronary Care (SEMICYUC), the guidelines are developed based on the best available evidence on diabetic foot infections, aimed at achieving greater clinical efficacy(AU)

Prevalence of peripheral artery disease and its associated risk factors in Spain: The ESTIME Study.

AIM: Several studies have demonstrated that patients with peripheral arterial disease (PAD), are at an increased risk of morbidity and mortality compared with those without PAD. However, few population-based studies have addressed the prevalence of PAD and intermittent claudication (IC). We assessed the prevalence of and the factors associated with PAD and IC in the Spanish population. METHODS: A cross sectional study with 1324 participants aged 55 to 84 years randomly selected from the census was conducted in 12 Spanish regions. The presence of PAD and IC was determined by an ankle-brachial index (ABI) <0.90 in either leg and by means of the Edinburgh questionnaire, respectively, fulfilled together with a detailed past history. All participants had blood pressure, body mass index, glycemia, and lipid profile measured. RESULTS: The response rate was 63.9% (846/1 324). ABI prevalence of PAD was 8.03% The prevalence of symptoms of definite or atypical IC was 6%. Subjects with an ABI <0.9 were more likely to be older, men, diabetics, current smokers, with coronary heart disease, with higher systolic pressure and with higher triglyceride levels than participants with ABI 0.9. CONCLUSIONS: ESTIME study confirms the high prevalence of asymptomatic PAD, and its relation with typical cardiovascular risk factors. ABI provides early diagnosis before claudication symptoms in a high proportion of patients. ABI could contribute to developing early prevention programmes.